Product Information
HM PAIN RELIEVER PM GELTAB is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0441 per EA under NDC 62011025601. Its NADAC has been published 475 times since Apr 13, 2016.
The High Outlier badge above means this manufacturer's average price in the Acetaminophen, Diphenhydramine HCl market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500; 25 mg/1; mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
62011025601
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/31/2015
Pharmacological Classes
Price Statistics
The NADAC for HM PAIN RELIEVER PM GELTAB has been published 475 times since Apr 13, 2016, and over the history we have for it it has risen 18.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0441 per EA |
|---|---|
| All-time high | $0.0552 (Dec 11, 2024) |
| All-time low | $0.0374 (Apr 13, 2016) |
| Median price | $0.0432 |
| Average price | $0.0438 |
| Largest weekly change | +18.4% (Sep 21, 2022) |
| Weeks tracked | 475 |
| Tracking since | Apr 13, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-12.1%
5Y
+5.1%
All
+18.1%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen, Diphenhydramine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HM PAIN RELIEVER PM GELTAB?
The current National Average Drug Acquisition Cost (NADAC) for HM PAIN RELIEVER PM GELTAB, manufactured by Strategic Sourcing Services LLC, is $0.0441 per EA (NDC 62011025601), effective May 14, 2025.
How has the price of HM PAIN RELIEVER PM GELTAB changed over time?
Over the history we have for it, the NADAC for HM PAIN RELIEVER PM GELTAB has risen 18.1%. It has been tracked across 475 weekly CMS publications since Apr 13, 2016.
What are the highest and lowest recorded NADAC prices for HM PAIN RELIEVER PM GELTAB?
Since Apr 13, 2016, the NADAC for HM PAIN RELIEVER PM GELTAB has ranged from a low of $0.0374 (Apr 13, 2016) to a high of $0.0552 (Dec 11, 2024), with a median of $0.0432 per EA.
Are there cheaper alternatives to HM PAIN RELIEVER PM GELTAB?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GNP PM PAIN RLF 25-500 MG CPLT, is $0.0439 per EA — about 0% below HM PAIN RELIEVER PM GELTAB.
Who manufactures HM PAIN RELIEVER PM GELTAB?
HM PAIN RELIEVER PM GELTAB (NDC 62011025601) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.